Experimental Hepatoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
117
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
African Burkitt's lymphoma
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
36
|
5
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hepatoma, Novikoff
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
125
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Hepatoma, Morris
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
124
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Cerebral Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Pathologic Function
|
120
|
2
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Esophageal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1254
|
270
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Malignant neoplasm of esophagus
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1286
|
214
|
0.300 |
None |
1.000 |
1 |
|
2006 |
2006 |
Brain Ischemia
|
disease |
Nervous System Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
358
|
5
|
0.300 |
None |
1.000 |
1 |
|
2009 |
2009 |
Burkitt Leukemia
|
disease |
Neoplasms; Infections; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
45
|
|
0.300 |
None |
1.000 |
1 |
|
2008 |
2008 |
Liver Neoplasms, Experimental
|
phenotype |
Digestive System Diseases; Neoplasms
|
Neoplastic Process; Experimental Model of Disease
|
152
|
|
0.300 |
None |
1.000 |
1 |
|
2017 |
2017 |
Intermittent Claudication
|
phenotype |
Pathological Conditions, Signs and Symptoms; Cardiovascular Diseases
|
Disease or Syndrome
|
60
|
69
|
0.200 |
None |
1.000 |
1 |
|
2013 |
2013 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Monocyte count result
|
phenotype |
|
Laboratory or Test Result
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Monocyte count procedure
|
phenotype |
|
Laboratory Procedure
|
139
|
296
|
0.100 |
None |
1.000 |
1 |
1
|
2016 |
2016 |
Malignant neoplasm of liver
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1649
|
88
|
0.010 |
None |
1.000 |
1 |
|
2008 |
2008 |
Hematopoietic Neoplasms
|
group |
Neoplasms; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
322
|
2
|
0.010 |
None |
1.000 |
1 |
|
2016 |
2016 |
AICARDI-GOUTIERES SYNDROME
|
disease |
Congenital, Hereditary, and Neonatal Diseases and Abnormalities; Immune System Diseases; Nervous System Diseases
|
Disease or Syndrome
|
117
|
12
|
0.010 |
None |
1.000 |
1 |
|
2007 |
2007 |
Tubular Aggregate Myopathy
|
disease |
Musculoskeletal Diseases; Nervous System Diseases
|
Disease or Syndrome
|
67
|
5
|
0.010 |
None |
1.000 |
1 |
|
2011 |
2011 |
Hyperactive behavior
|
phenotype |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases
|
Mental or Behavioral Dysfunction
|
1263
|
112
|
0.010 |
None |
1.000 |
1 |
|
2012 |
2012 |
Neurodegenerative Disorders
|
group |
Nervous System Diseases
|
Disease or Syndrome
|
1515
|
85
|
0.010 |
None |
1.000 |
1 |
|
2015 |
2015 |
Primary Effusion Lymphoma
|
disease |
Neoplasms; Immune System Diseases; Hemic and Lymphatic Diseases
|
Neoplastic Process
|
169
|
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Malignant Glioma
|
disease |
Neoplasms
|
Neoplastic Process
|
724
|
22
|
0.010 |
None |
1.000 |
1 |
|
2005 |
2005 |
Fulminant hepatitis
|
disease |
Digestive System Diseases
|
Disease or Syndrome
|
57
|
1
|
0.010 |
None |
1.000 |
1 |
|
2010 |
2010 |
Cervix carcinoma
|
disease |
Neoplasms; Female Urogenital Diseases and Pregnancy Complications
|
Neoplastic Process
|
1881
|
283
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Primary Progressive Aphasia (disorder)
|
disease |
Pathological Conditions, Signs and Symptoms; Nervous System Diseases; Mental Disorders
|
Mental or Behavioral Dysfunction
|
51
|
11
|
0.010 |
None |
1.000 |
1 |
|
2017 |
2017 |